DRUG · Mapped RxNorm record
docetaxel
Normalized identity: docetaxelView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer
NCT02145078
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
pemetrexed disodium
Normalized identity: pemetrexed disodiumView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
gemcitabine hydrochloride
Normalized identity: gemcitabine hydrochlorideView linked drug · Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
laboratory biomarker analysis
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedGene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer
Design: INTERVENTIONAL · Status: TERMINATED · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Recurrent Non-small Cell Lung Cancerunresolved
Stage IV Non-small Cell Lung Cancerunresolved
Interventions
docetaxelDRUG · verified · RxNorm: docetaxel
pemetrexed disodiumDRUG · verified · RxNorm: pemetrexed disodium
gemcitabine hydrochlorideDRUG · verified · RxNorm: gemcitabine hydrochloride
Sponsors & collaborators
Barbara Ann Karmanos Cancer Institutelead sponsor
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02145078 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.